Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Glycominds
company
About
Glycominds develops and commercializes autoimmune and chronic inflammatory disease management tools focused on multiple sclerosis.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $1M
- Industries
- Biotechnology,Health Diagnostics
- Founded date
- Jan 1, 1999
- Number Of Employee
- 11 - 50
- Operating Status
- Close
Glycominds, a molecular diagnostics company, develops and commercializes autoimmune and chronic inflammatory disease management tools and services with a distinctive focus on the Multiple Sclerosis market. Their proprietary tests allow physicians to help identify patients at a higher risk for more severe disease outcomes.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$1M
Glycominds has raised a total of
$1M
in funding over 2 rounds. Their latest funding was raised on
Jan 1, 2005 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 1, 2005 | Series Unknown | $1M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Glycominds is funded by 1 investors.
Millennium II Materials Technology Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Millennium II Materials Technology Fund
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
